English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

We want to congratulate Baillie, Moloney, Mueller, Dorn, Branson, and Ohlssen on a high-impactful article. We sincerely appreciate that Baillie et al. ( 2022 ) proposed their definition of data science, which can be tailored to the industry of drug development. They also highlighted issues with scientific practice from five perspectives, leading to a framework for good practice that we would follow in the pharmaceutical industry, should the framework be strengthened by adding one more perspective, the causal perspective.

Comment on “Good Data Science Practice: Moving towards a Code of Practice for Drug Development”